Biotech Pre-Seed Investors & VC Firms
896 firms in this list, with a median first check of $270K. 229 of them lead rounds. Generated from verified public data and updated continuously.
Creator Fund
LondonPre-Seed–Series A$1.1M
21 people
Axial VC
San FranciscoPre-Seed–Series A$100K – $5M
2 people
Kobe University Capital
KobePre-Seed–Growth
10 people
DNA Capital
São PauloPre-Seed–Late Stage$100K – $5M
15 people
Vesna Advisors
LuxembourgPre-Seed–Series A$200K – $700K
6 people
Zinc
LondonPre-Seed–Seed
15 people
Amino Collective
BerlinPre-Seed–Series A$216K – $1.6M
8 people
QUBIS
BelfastPre-Seed–Series A$12.7K – $127K
11 people
ATOORO FUND
Tel AvivPre-Seed–Series A$500K – $5M
2 people
Page One Ventures
Silicon ValleyPre-Seed–Series A
4 people
Ripple Ventures
TorontoPre-Seed–Seed$250K – $1M
13 people
Foreground Capital
BostonPre-Seed–Series B
9 people
PsyMed Ventures
BerkeleyPre-Seed–Series A
12 people
Breakthrough Victoria
MelbournePre-Seed–Late Stage
11 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
Shanda Group
Redwood CityPre-Seed–Series A
20 people
Cantos Ventures
San FranciscoPre-Seed–Series B$400K – $1.5M
4 people
FREEFLOW
BerkeleyPre-Seed–Series B
10 people
Okapi Venture Capital
Newport BeachPre-Seed–Series A$750K – $3M
4 people
Capital Cell
BarcelonaPre-Seed–Growth
AQC Capital
MontrealPre-Seed–Series A
20 people
FSG
LundPre-Seed–Growth$1.1M – $6.5M
8 people
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $500K
11 people
TechVision Fund
AachenPre-Seed–Series A$550K – $2.2M
17 people
Related lists
Pre-Seed Investors & VC Firms (5679)Biotech Investors & VC Firms (2107)Pre-Seed Investors & VC Firms in United States (2090)AI & Machine Learning Pre-Seed Investors & VC Firms (1855)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)SaaS Pre-Seed Investors & VC Firms (1575)Pre-Seed Investors & VC Firms in Global (1485)Fintech Pre-Seed Investors & VC Firms (1477)Healthtech Pre-Seed Investors & VC Firms (1328)
Data sourced from public filings and firms' own websites — see our methodology.





































































